Capillary Electrophoresis System Optimizes IgG Purity Analysis
The advanced capillary electrophoresis system, Maurice, from ProteinSimple is used for the quantitative analysis of identity, purity, and heterogeneity profiles of biopharmaceuticals. The system includes a native fluorescence detection mode, capability for size-based separation across a broad range of molecules, and offers optimized methods for IgG purity analysis. Maurice includes a cartridge for each application, which allows researchers to swap between applications without cleanup steps or a risk of cross-contamination. The platform includes three systems: Maurice C. for quantitative pI and Charge heterogeneity analysis, Maurice S. for IgG purity analysis by CE-SDS, and Maurice which completes both applications.
|
|---|
|
Current Issue
Transcriptomics and the Production of Recombinant Therapeutics
Transcriptomics plays a role in influencing the production of recombinant therapeutics in microbial and mammalian hosts.
Let the Learning Commence
By minding gaps in industry knowledge, bio/pharma companies can avoid development pitfalls.
Meeting the Challenge of Patient-Centered Clinical Trials
Logistics manufacturers are adapting to explosive growth in the use of direct-to-patient clinical trials. Michael Sweeney, director of patient-centric logistics at World Courier Group, discusses the new model’s impact.
Outsourcing
Rentschler Fill Solutions Announces Agreement for US-Market Drug
Rentschler Fill Solutions and Ultragenyx announce fill and finish agreement for the US commercial supply of Mepsevii.
Vetter Launches Use-Centered Approach to Improve Injections
Vetter anounced the Open Innovation Challenge to examine the applicability of digital trends to injection systems.
CMOs Expand Manufacturing Capacities
New and expanded facilities point to the continuing growth of the biopharmaceutical industry.
Outsourcing Analytical Methods
Open communication channels between all the parties involved is key when outsourcing analytical methods, says Susan Schniepp, distinguished fellow at Regulatory Compliance Associates.
Standards/Regulations
CGMP Violations Found at India Facility
FDA sent a warning letter to Goran Pharma Private Limited citing inadequate quality control violations.
Trump Drug Pricing Plan Outlines Rule Changes Pharma Can Live With
President Donald Trump announced his strategy for making prescription medicines more affordable and accessible in the United States.
Understanding Validation and Technical Transfer, Part 2
A validation plan developed to support a process unrelated to bio-pharmaceutical manufacture is applied to biopharmaceutical processes and systems.
Sponsored Links
